SCHEMBL7429249

SCHEMBL7429249

Cc1cc(C)cc(CCO)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.42
ALDH1A1 P00352 3/20 0.41
KDM4E B2RXH2 1/20 0.41
ALOX5 P09917 1/20 0.41
GAA P10253 1/20 0.41
MAPT P10636 1/20 0.41
BACE1 P56817 1/20 0.41
CA2 P00918 1/20 0.40
PGK1 P00558 1/20 0.39
PGK2 P07205 1/20 0.39
CYP4F2 P78329 3/20 0.36
CYP4A11 Q02928 3/20 0.36
TSHR P16473 1/20 0.36
IDH1 O75874 1/20 0.36
CNR1 P21554 1/20 0.36
TPMT P51580 1/20 0.35
HPGD P15428 1/20 0.34
MAOA P21397 1/20 0.34
CISD1 Q9NZ45 1/20 0.34
TKT P29401 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6418650 0.94 PGK1 (0.44) TDP1ALDH1A1KDM4EALOX5GAA
SCHEMBL27667787 0.89 ALDH1A1 (0.52) TDP1ALDH1A1KDM4EALOX5GAA
SCHEMBL80615 0.84 TNKS2 (0.47) ALDH1A1KDM4ECA2PGK1PGK2
SCHEMBL8417016 0.84 PTGS1 (0.37) TDP1ALDH1A1KDM4EALOX5GAA
SCHEMBL1247063 0.84 PGK1 (0.38) TDP1ALDH1A1KDM4EALOX5GAA
SCHEMBL13180741 0.84 CNR1 (0.38) TDP1ALDH1A1KDM4EALOX5GAA
SCHEMBL16962202 0.84 TACR1 (0.38) TDP1ALDH1A1KDM4EALOX5GAA
SCHEMBL28266224 0.82 TNKS2 (0.41) ALDH1A1KDM4ECA2PGK1PGK2
SCHEMBL3690305 0.82 ALDH1A1 (0.44) ALDH1A1PGK1PGK2TSHRIDH1
SCHEMBL11766486 0.80 CALM1 (0.44) ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102154431-A Kinetic resolution method of secondary alcohol UNIV ZHEJIANG 2011-08-17 CN claimed
CN-102127584-A Dynamic kinetic method for resolving secondary alcohol UNIV ZHEJIANG 2011-07-20 CN claimed
US-20230399322-A1 EIF4E INHIBITORS AND USES THEREOF PIC Therapeutics, Inc. 2023-12-14 US disclosed
US-20230399322-A1 EIF4E INHIBITORS AND USES THEREOF PIC Therapeutics, Inc. 2023-12-14 US disclosed
US-11753403-B2 EIF4E inhibitors and uses thereof PIC Therapeutics, Inc. (US) 2023-09-12 US disclosed
US-11753403-B2 EIF4E inhibitors and uses thereof PIC Therapeutics, Inc. (US) 2023-09-12 US disclosed
CN-113493450-B Ligand compound, preparation method thereof and application thereof in asymmetric reaction 中国科学院福建物质结构研究所 2023-07-25 CN disclosed
EP-3915998-B1 APPLICATION OF SALIDROSIDE DERIVATIVE IN SKIN-WHITENING AGENT FOR EXTERNAL USE SHANGHAI CHEERMORE BIOLOGICAL TECH CO LTD (CN) 2023-01-18 EP disclosed
CN-113493450-A Ligand compound, preparation method thereof and application thereof in asymmetric reaction 中国科学院福建物质结构研究所 2021-10-12 CN disclosed
WO-2021178488-A1 EIF4E INHIBITORS AND USES THEREOF PIC Therapeutics, Inc. (US) 2021-09-10 WO disclosed
CN-108503579-A Fentanyl analog and its application 南京医科大学 2018-09-07 CN disclosed
CN-102154431-A Kinetic resolution method of secondary alcohol UNIV ZHEJIANG 2011-08-17 CN disclosed
CN-102127584-A Dynamic kinetic method for resolving secondary alcohol UNIV ZHEJIANG 2011-07-20 CN disclosed
CN-100376292-C Deodorant composition TAKASAGO PERFUMERY CO LTD (JP) 2008-03-26 CN disclosed
CN-1732019-A Deodorant composition TAKASAGO PERFUMERY CO LTD (JP) 2006-02-08 CN disclosed
EP-1263755-A2 CYCLIC BETA-AMINO ACID DERIVATIVES AS INHIBITORS OF MATRIX METALLOPROTEASES AND TNF-ALPHA Bristol-Myers Squibb Pharma Company (US) 2002-12-11 EP disclosed
WO-2001070673-A2 CYCLIC β-AMINO ACID DERIVATIVES AS INHIBITORS OF MATRIX METALLOPROTEASES AND TNF-$g(a) BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) 2001-09-27 WO disclosed
EP-0191394-B1 ISOTHIOUREAS, PROCESS FOR THEIR PREPARATION AND THEIR USE TO COMBAT UNDESIRABLE PLANT GROWTH BASF Aktiengesellschaft (DE) 1989-12-06 EP disclosed
US-4689068-A HERBICIDES BASF AKTIENGESELLSCHAFT (DE) 1987-08-25 US disclosed
EP-0191394-A1 Isothioureas, process for their preparation and their use to combat undesirable plant growth BASF Aktiengesellschaft (DE) 1986-08-20 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230399322-A1 EIF4E INHIBITORS AND USES THEREOF EIF4E, EIF4EBP1, EIF4A1 TDP1 1025/4885ALDH1A1 4776/4885KDM4E 710/4885
US-11753403-B2 EIF4E inhibitors and uses thereof EIF4E, EIF4EBP1, EIF4A1 TDP1 1025/4885ALDH1A1 4776/4885KDM4E 710/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.